Future Scope of Molecular Diagnostics Market is Witness to Grow High CAGR till 2025

Global Hematology Diagnostics Market was valued US$3.41 Bn in 2017 and is estimated to reach US$5.98 Bn by 2026 at a CAGR of 7.27%.

Based on end user hematology diagnostics market is classified into hospitals & clinics, diagnostic laboratories, academic institute, commercial service providers, and others.

Commercial service providers is estimated to hold the highest share of market due to rising awareness for hematology testing, automated testing, efficient cost and management.

Hematology consumables segment lead the market during forecast period due to increasing awareness of blood disorders among healthcare specialists will grow the demand for hematology analyzers.

Rising the blood donation, increasing incidents of blood disorders, disease like blood cancer and awareness regarding disorders of blood, technical advancements in blood analyzers, rising demand for hematology diagnostics from patients are major drivers of hematology diagnostics market and at same time lack of awareness, growing penetration of POC testing hematology analyzers in emerging economies, high cost of diagnostics and poor insurance for diagnostics will hamper the market.In terms of region, North America is hold the largest share of the market hematology diagnostics in forecast period due to rising developments of automated technologies in instruments, rising the healthcare infrastructure and analysis blood product quality.

Followed by Europe, Asia Pacific, Middle East & Africa, and Latin America.

According to the new market research report “Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the Therapeutic Drug Monitoring Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443The TDM Market growth is largely driven by factors such as the rising number of organ transplant procedures, the use of TDM across various therapeutic fields, the increasing preference for precision medicine, a growing focus on R related to TDM, and technological advancements in immunoassay instruments.

Increasing adoption in the treatment of autoimmune diseases is expected to provide a wide range of growth opportunities for players in the market.Consumables is expected to hold the largest share of the therapeutic drug monitoring market in 2020On the basis of product, the market is segmented into equipment and consumables.

In 2019, consumables segment accounted for the largest market share, primarily due to the repeat purchases of kits and reagents and the increasing number of immunoassay tests being performed across the globe.Browse in-depth TOC on “Therapeutic Drug Monitoring Market“288 – Tables35 – Figures241 – PagesImmunoassays is expected to hold the largest share of the market in 2020Based on technology, the TDM Market is segmented into immunoassays and chromatography-MS.

In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation.Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020On the basis of class of drug, the market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs.

During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.Hospital laboratories segment commanded the largest share of the TDM Market in 2019By end user, the market is segmented into hospital laboratories, commercial & private laboratories, and other end users.

Hospital laboratories accounted for the largest share of the market in 2019.

The global thyroid function test market size is accounted to grow at a significant CAGR of around 6% during the forecast period 2021 to 2027.

Moreover, the increasing awareness regarding health and early diagnosis of disease and the availability of advanced diagnosis centers is anticipated to drive the market over the forecast period.The report titled "Thyroid Function Test Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Thyroid Function Test industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others.

Furthermore, the report includes detailed quantitative and qualitative analysis of the global Thyroid Function Test market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.Browse Full report on Global Thyroid Function Test Market report at: https://www.researchcorridor.com/thyroid-function-tests-market/The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others.

Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.Thyroid Function Test Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis.

Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years.

The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.The Data Thyroid Function Test Market Segmentation:By Test:TSH TestT4 TestT3 TestOthersBy End-User:Hospital & ClinicsDiagnostic LaboratoryOthersBy Region:North AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaTo know more about the study, make an inquiry before purchase @ https://www.researchcorridor.com/inquiry/?id=13377List of Key Companies:Abbott Laboratories, Inc.bioMerieux SA.Beckman Coulter, Inc.Hoffman-La Roche Ltd.DiaSorin S.p.A.Quidel CorporationRandox Laboratories Ltd.Qualigen, Inc.Siemens HealthineersThermo Fisher Scientific CorporationKey Questions Answered by Thyroid Function Test Market ReportProduct popularity and adoption based on various country-level dynamicsRegional presence and product development for leading market participantsMarket forecasts and trend analysis based on ongoing investments and economic growth in key countriesCompetitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among othersnumber of employees and market concentration, among othersTo know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=13377About Us:Research Corridor is a global market research firm.

Antibiotics Market The global antibiotics market is expected to reach USD 40.78 billion by 2025.

Global antibiotics market report presents thorough competitive analysis along with the market Size, share, and Future scope.

This study also analyzes the opportunities, market drivers, and challenges.Request sample copy of this report at: https://www.adroitmarketresearch.com/contacts/request-sample/1282Major players in the global antibiotics market are Abbott Laboratories, Merck & Co. Inc., GlaxoSmithKline Plc, F.Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., Novartis International AG, and Cipla Ltd among others.Adroit Market Research report on global antibiotics market gives a quantitative narration of the market demand, trends, drivers, restraints and opportunities spanning from 2015 to 2025.

Additionally, the market has been assessed based on Porter's five forces analysis, along with the depiction of the industry’s value chain.

Many low and middle income countries face both antibiotics excess and access issues.

A 2015 study by the Centers for Disease Dynamics and Control found that global antibiotic consumption had increased by 65% in the past 15 years (from 21.1 billion to 34.8 billion defined daily doses).

Pain Management MPain ManagementPain Management Market Size  Market Size arket Size Research Report: By Devices (Neurostimulation, Ablation Devices, Others), Drugs (NSAIDS, Anticonvulsants, Opioids, Others), Indication (Neuropathic Pain, Fibromyalgia, Others), Mode of Purchase, End-User – Global Forecast Till 2023The “Pain Management Market Size” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.The Pain Management Market Size will provide valuable insight with an emphasis on the global market including some of the major players such As, Abbott Laboratories, Abbvie, Allergan, Astellas Pharma, AstraZeneca plc, Bayer AG, Codman And Shurtleff, Inc, DJO Global LLC, Eli Lilly & Company, Endo Health Solutions, F. Hoffmann-La Roche Ltd, Forest Laboratories, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Mallinckrodt plc, Medtronic PLC, ST. Jude Medical, Inc., Boston Scientific Corporation, Pfizer Inc., Halyard Health, Inc., Smiths Medical, B. Braun Melsungen AG, Neurotech Na, Inc., Becton, Dickinson and Company, Nevro Corp., Merck & Co. Inc., Novartis AG, Purdue Pharma LP, Sanofi, Stryker Corporation, Teva Pharmaceuticals, and others.For Market Pain Management Market Size analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and proposals, which more specifically include valuable information By key applications and consumption, key regions and consumption, key Global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply.The global pain management market is segmented on the basis of type of pain management devices, type of pain management drugs, indication, mode of purchase, and end-user.On the basis of type of pain management devices, the market is classified as neurostimulation devices, analgesic infusion pumps, and ablation devices.

Neurostimulation devices are further segmented into Transcutaneous Electrical Nerve Stimulation (TENS) devices and Spinal Cord Stimulation (SCS) devices.

Ablation devices are further segmented into RF ablation devices and cryoablation devices.On the basis of type of pain management drugs, the market is classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), anticonvulsants, anesthetics, opioids, antimigraine agents, antidepressants, and others.

The opioids segment is further classified as oxycodones, hydrocodones, tramadol, morphine, codeine, fentanyl, meperidine, methadone, and others.On the basis of indication, the market is classified as neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, and others.On the basis of the mode of purchase, the market is classified as over the counter and prescription-based.On the basis of end-user, the market is classified as hospitals and clinics, pharmaceutical companies, medical device companies, research and academic institutes, and others.Pain Management Market Size Segment by Regions, regional analysis covers:North America(United States, Canada and Mexico)Europe(Germany, France, UK, Russia and Italy)Asia-Pacific(China, Japan, Korea, India and Southeast Asia)South America(Brazil, Argentina, Colombia etc.

)Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/pain-management-market-5975Reasons to Purchase this ReportQualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factorsProvision of market value (USD Billion) data for each segment and sub-segmentIndicates the region and segment that is expected to witness the fastest growth as well as to dominate the marketAnalysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each regionThe competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiledThe report also appraises the supervisory scenarios which affect various decisions in the market.

With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Pain Management Market Size.

 UpMarketResearch offers a latest published report on “Global Bone & Mineral Testing Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.

It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.

Bone & Mineral Testing market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.

The statistics are represented in graphical format for a clear understanding on facts and figures.For more information @ https://www.upmarketresearch.com/home/enquiry_before_buying/6885 The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.

The report for Bone & Mineral Testing market industry analysis & forecast 2018-2025 is segmented into Product Segment, Application Segment & Major players.Region-wise Analysis Global Bone & Mineral Testing Market covers:North AmericaEuropeChinaJapanIndiaSoutheast AsiaOther regions (Central & South America, Middle East & Africa)The major manufacturers covered in this report   Abbott laboratoriesbioMrieuxDiasorinQuidelRocheSiemens HealthcareBio-Rad LaboratoriesEpitope DiagnosticsOrtho-Clinical DiagnosticsEnzo Life SciencesOn the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into     By product      Assays/ConsumablesInstruments   By technology       Enzyme-linked Immunosorbent Assay (ELISA)Clinical Laboratory Improvement Amendments  By Application, the market can be split intoVitamin D TestingBone MetabolismKey StakeholdersBone & Mineral Testing ManufacturersBone & Mineral Testing Distributors/Traders/WholesalersBone & Mineral Testing Subcomponent ManufacturersIndustry AssociationDownstream VendorsThe Report covers in-depth analysis as follows:Chapter 1 Industry Overview of Bone & Mineral TestingChapter 2 Manufacturing Cost Structure Analysis of Bone & Mineral TestingChapter 3 Technical Data and Manufacturing Plants Analysis of Bone & Mineral TestingChapter 4 Global Bone & Mineral Testing Overall Market OverviewChapter 5 Bone & Mineral Testing Regional Market AnalysisChapter 6 Global 2013-2018E Bone & Mineral Testing Segment Market Analysis (by Type)Chapter 7 Global 2013-2018E Bone & Mineral Testing Segment Market Analysis (by Application)Chapter 8 Major Manufacturers Analysis of Bone & Mineral TestingChapter 9 Development Trend of Analysis of Bone & Mineral Testing MarketChapter 10 Bone & Mineral Testing Marketing Type AnalysisChapter 11 Consumers Analysis of Bone & Mineral TestingChapter 12 Conclusion of the Global Bone & Mineral Testing Market Professional Survey Report 2017 Buy this report @ https://www.upmarketresearch.com/buy/bone-and-mineral-testing-market “Global Bone & Mineral Testing Market Industry Analysis and Forecast 2018-2025” report helps the clients to take business decisions and to understand strategies of major players in the industry.

The global insulin pump market is likely to gain impetus from the ever-increasing prevalence of diabetes reported worldwide.

Fortune Business Insights™ provided this information in a recent report, titled, “Insulin Pump Market Size, Share & Industry Analysis, By Product Type (Pumps (Tethered Pumps, Patch Pumps, and Others), and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027.” The report further states that the insulin pump market size was USD 4.15 billion in 2019 and is projected to reach USD 8.50 billion by 2027, exhibiting a CAGR of 9.4% during the forecast period.Please visit:https://www.fortunebusinessinsights.com/insulin-pump-market-102735automated insulin pump system.Fortune Business Insights™ lists out all the renowned organizations present in the insulin pumps market.

They are as follows:MedtronicInsulet CorporationHoffmann-La Roche Ltd.Tandem Diabetes Care, Inc.YPSOMEDOthersThe emergence of COVID-19 has brought the world to a standstill.

We understand that this health crisis has brought an unprecedented impact on businesses across industries.

Rising support from governments and several companies can help in the fight against this highly contagious disease.

Overall, almost every sector is anticipated to be impacted by the pandemic.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/insulin-pump-market-102735Segment-Type 2 Diabetes Segment to Grow Remarkably Backed by New Product LaunchesIn terms of disease indication, the market is bifurcated into type 1 diabetes and type 2 diabetes.

The Diabetics Assays Market research report elaborates on growth, size, current industry trends, and key players of the industry on the basis of in-depth data mining and industry analysis.

The content of the market study ensures intellectual insights giving a better understanding of the ideal opportunities in the Diabetics Assays market.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the Diabetics Assays include InSphero AG, Abbott Laboratories, American Laboratory Products Company, Beckmann Coulter Inc., Bio RAD laboratories Inc., Ortho clinical diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG, PTS Diagnostics and others.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Request FREE sample copy of the report “Global DIABETICS ASSAYS Market” at: https://www.valuemarketresearch.com/contact/diabetics-assays-market/download-sampleMarket SegmentationThe broad Diabetics Assays has been sub-grouped into the Product Type, Method, End-Users and region.

The report studies these subsets with respect to the geographical segmentation.

The strategists can gain a detailed insight and devise appropriate strategies to target specific market.

The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness, and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives.This report segments the creatinine measurement market on the basis of type, type of sample, end-user, product, and region.

By type, the market is segmented into Jaffe’s kinetic method and enzymatic method.

In 2018, Jaffe’s kinetic method segment is estimated to account for the largest share of the creatinine measurement market, as it is the oldest and most conventional method for creatinine measurement in clinical samples.

Additionally, the widespread availability and cost-effectiveness of kits and reagents used in Jaffe’s kinetic method is another major factor responsible for the large share of this segment.Based on the type of sample, the market is segmented into blood/serum and urine samples.

The blood sample segment accounted for the largest share of the creatinine measurement market in 2017 due to the increased accuracy and low risk of contamination.

This segment is also expected to witness the highest growth over the forecast period, as it is the most preferred sample type for accurate measurement of creatinine levels.For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385 The diagnostic laboratories segment is expected to witness the highest growth over the forecast period as various market players are entering into long-term collaborations with diagnostic laboratories in order to increase their presence in the creatinine measurement market.

Theranostics Market HighlightsThe global theranostics market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period.

Theranostics is a proposed diagnostic methodology for personalizing therapeutic intervention and the integration of imaging and therapy in a single system, enabling simultaneous therapy and follow-up of the treatment.

Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases.

In contrast, lack of proper defined regulations for theranostics tests and inadequate reimbursement facilities in most of the countries are anticipated to impede the market growth during the forecast period.Molecular theranostics is a major field which includes small biochemical moieties and biomacromolecules.

Theranostics is important for personalized as well as precision medicine that provides therapeutic outcome so that a physician can make a decision pertaining to the course of treatment for the patient.Theranostics Market SegmentationThe global theranostics market has been segmented into the therapeutic area, technology, end user, and region.By therapeutic area, the market has been segmented into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others.

The oncology segment is further categorized into breast cancer, colorectal cancer, lung cancer, cervical cancer, and others.On the basis of technology, the market has been divided into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others.

Market ScenarioThe Global Blood Glucose Monitoring Market is predicted to register 10.7% CAGR during the forecast period (2017-2023) owing to the increased diabetic population across the globe, asserts Market Research Future (MRFR).

Blood Glucose Monitoring is referred to as the process of testing diabetes level in the blood which helps to identify the glucose level in the blood within a specific target range.Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4921The various blood glucose monitoring devices available in the market are termed as blood glucose meter.

These devices offer useful insights to manage diabetes and helps in tracking the progress of treatment goal.

Moreover, physical inactiveness and unhealthy diet has further contributed to the market growth.Increasing awareness of diabetes, development of new technologies, and rising investment in research and development activities have fueled the market growth during the appraisal period.

Huge surge in the geriatric population and rising product launch and approvals are further influencing the market growth.On the flip side, high cost associated with the monitoring and diagnosis of diseases is one of the major concerns considered to impede the market growth in the coming years.Moreover, product recalls coupled with inadequate reimbursements are some of the factors presumed to dampen the market growth to an extent.Global Blood Glucose Monitoring Market: Segmental AnalysisThe Global Blood Glucose Monitoring Market has been segmented on the basis of application, product type, end-user, and region.By mode of product type, the global blood glucose monitoring market has been segmented into continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.By mode of application, the global blood glucose monitoring market has been segmented intotype 1 diabetes, type 2 diabetes, and others.Type-I and type-II diabetes are further sub-segmented into pediatrics and adult.

The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.By mode of end-users, the global blood glucose monitoring market has been segmented intohospitals, diagnostic centers, research centers, clinics,and home care diagnostics.

Activated clotting time testing is a device market which is specially designed to calculate the coagulation end-points in citrated whole blood, plasma samples or blood.

Optical detection, mechanical detection, fluorescent based detention etc.

are some of the technology used in activated clotting time testing.

Rising demand for automated hemostasis instrument is the major factor fueling the growth of this market.activated clotting time testing market is set to witness a stable CAGR in the forecast period of 2019- 2026.

The report contains data of the base year 2018 and historic year 2017.

Increasing blood related and cardiovascular disorder among population is the major factor for the growth of this market.This Activated Clotting Time Testing Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.

COVID-19 Impact Analysis on Medical Biosensors Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.

The report encompasses data regarding market share and recent developments by key players.

Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Medical Biosensors Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/medical-biosensors-market/download-sampleMarket DynamicsThe global medical biosensors market is projected to emerge at a robust rate during the forecast period.

Rising technology advancements in microelectronics and biotechnology, increasing market penetration of electronic medical records, growing patient awareness levels, and enhanced applications in the cardiac care and point of care segment complement market growth.

However, the pace of medical biosensors technologies adaptability is sluggish, which is curbing the global market expansion.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.

Market HighlightsGlobal Chemiluminescence Immunoassay (CLIA) Analyzers Market is expected to register a CAGR of 6.4% during the forecast period, with a market value of USD 8,205.22 Million till 2026.

Chemiluminescence immunoassay (CLIA) analyzers have been growing at a rapid pace over the last few years.

The global chemiluminescence immunoassay (CLIA) analyzers market is rapidly booming due to the increasing prevalence of chronic and acute diseases, technological advancements, and high specificity provided by chemiluminescence immunoassay (CLIA) analyzers.

However, the scarcity of skilled labor/healthcare professionals and stringent regulatory policies are hampering the growth of the market.

Likewise, entry of market players in developing economies is likely to pose an opportunity for global chemiluminescence immunoassay (CLIA) analyzers market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8783Segment AnalysisThe Global Chemiluminescence Immunoassay (CLIA) Analyzers Market is segmented into Type, Product, Application, and End User.

Based on the application, the global chemiluminescence immunoassay (CLIA) analyzers market has been categorized as hepatitis and retroviruses, oncology & endocrinology, cardiac markers, infectious disease, bone and mineral disorders, auto-immune diseases, allergy, GI stool testing, drug discovery and development, and others.